Advisory Board and Editors Oncology

PeerJ Factsheet
A one-page facts and stats PDF, to help when considering journal options with your co-authors.

Irina U Agoulnik

Associate Professor at FIU College of Medicine. Director of Histopathology Core. Academic Editor of PLoS ONE.

Maria Cristina Albertini

From 2008, Professor of General Pathology at the Department of Biomolecular Sciences (DISB) of the University of Urbino (Italy).
Member of the European TRANSAUTOPHAGY Cost Action.

Ludmil B Alexandrov

I am an enthusiastic early career scientist with an interdisciplinary training and a strong computational background. My interests lie in leveraging the information hidden in large-scale omics data for better understanding of the mutational processes causing human cancer, for identifying potential cancer prevention strategies, and for developing novel approaches for targeted cancer treatment.

Praveen Arany

Training: Dental Research, Bioengineering.
Postdoctoral: TGF-beta, wound healing, regeneration, radiation biology, light biology, stem cells, biomaterial, Lasers.
Current: Clinical translational research and Molecular mechanisms.
Positions: Past-President, NAALT; President-Elect WALT, Co-Chair SPIE, Chair, ASLMS
Interests: Signal Transduction, Lasers, Biological regulation.

Ruth Arnon

President of the Israel Academy of Sciences & Humanities. Former VP of the Weizmann Institute of Science. Significant contributions to vaccine development, cancer research & parasitic diseases. Has served as President of EFIS and Secretary-General of the IUIS. Awards include the Robert Koch Prize in Medical Sciences, Spain’s Diaz Memorial Prize, France's Legion of Honor, the Hadassah World Organization's Women of Distinction Award, the Wolf Prize for Medicine, the Rothschild Prize for Biology.

Nebojsa N Arsenijevic

Professor of Immunology and Basic Oncology; Center for Molecular Medicine and Stem Cells Research, Faculty of Medical Sciences, University of Kragujevac.

Peter D Baade

I am a Biostatistician working in descriptive cancer epidemiology in Queensland, Australia, with a strong research interest in describing temporal and spatial patterns of cancer. My work has a particular focus on health inequalities in cancer-related outcomes. I have published over 180 peer-reviewed journal articles in addition to 20+ commissioned peer-reviewed monographs, and been a chief investigator on externally funded research grants totaling over $7 million. I regularly review scientific manuscripts and grant applications for national and international funding bodies.

Robert C. Bast

Vice President for Translational Research, The University of Texas MD Anderson Cancer Center, Houston, TX; Harry Carothers Wiess Distinguished University Chair for Cancer Research, Rosalind Franklin Award for Excellence in Ovarian Cancer Research, Ovarian Cancer National Alliance; Award for Excellence in Gynecologic Oncology, International Gynecologic Cancer Society.

Anaïs Baudot

I'm a Systems Biologist with a background in Biology, Genetics and Bioinformatics. I hold a PhD from the Aix-Marseille University. After a Post-Doc in the CNIO (Madrid, Spain), I got a CNRS Researcher position in 2010. I've working since then in the Marseille Institute of Mathematics (CNRS-AMU). I'm interested in -omics studies (interactomes), Networks (partitioning, boolean modelling), and questions related to human diseases, in particular complex diseases, cancers and comorbidities.

Jürgen C Becker

Prof. Becker is heading the Department of Translational Oncology at the Westdeutsches Tumorzentrum in Essen with a focus on skin cancer research.

Jürgen C. Becker received his medical degree from the Medical School Hannover for his work on the immune regulatory capacity of natural killer cells on the adaptive immune system. After finishing medical school he was first trained in Dermatology at the University of Würzburg and then as well in Tumor Immunology at the Scripps Research Institute, La Jolla, and the Danish Cancer Society, Copenhagen. For his characterization of the impact of therapeutic interventions on the adaptive immune responses against melanoma in preclinical models he received the PhD in Immunology. In 2003 he became full professor for Dermato-Oncology in Würzburg, where he coordinated a Clinical Research Group focusing on the tumor microenvironment. In 2010, he was appointed as director of General Dermatology at the Medical University of Graz. There, in parallel to his clinical duties, he successfully attracted the FP7 EU-project IMMOMEC (IMmune MOdulating strategies for treatment of MErkel cell Carcinoma, www.immomec.eu) and became deputy speaker of the graduate training program DK-MOLIN (Doktoratskolleg MOLecular fundamentals of INflammation, www.medunigraz.at/DK-MOLIN/).

Søren M Bentzen

Professor, Director of the Division of Biostatistics & Medical Informatics, Department of Epidemiology and Public Health, University of Maryland - Baltimore. Adjunct professor University of Copenhagen, Denmark. 20+ awards and honors incl. ESTRO Gold Medal, MD Anderson Distinguished Alumnus Award, Honorary Life member Assoc. of Radiation Oncologists of India & Belgian Soc. for Therapeutic Radiology and Oncology. 370+ publications, H-index 62 Web of Science.

Dominique Bonnet

Obtained her PhD degree in the University of Paris VII in 1993, and trained as a post-doc in Prof. John Dick’s group in Toronto. In 1998, she became Group Leader at the Coriell Institute for Medical Research and Assistant Professor, University of Medicine and Dentistry of New Jersey. In 2001, she joined the London Research Institute. Since 2002, she is also Professor, University College of London and Senior Lecturer at the Institute of Child Health.